Telix Pharmaceuticals Limited (TLPPF) Capital expenditures 2023–2025
Telix Pharmaceuticals Limited (TLPPF) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$25.7MFY2025 · since FY2023: $6.3M → $25.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $25.7M | +181.8% |
| FY2024 | $9.1M | +44.6% |
| FY2023 | $6.3M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More TLPPF financial trends
TLPPF RevenueTLPPF Net incomeTLPPF Net marginTLPPF Gross profitTLPPF Gross marginTLPPF Operating incomeTLPPF Operating marginTLPPF Operating cash flowTLPPF Free cash flowTLPPF Return on equityTLPPF Stock buybacksTLPPF Dividends paidTLPPF Total assetsTLPPF Total liabilitiesTLPPF Shareholders’ equityTLPPF overview →